BioLASCO Taiwan Co., Ltd. (TPEX:6662)

Market Cap	742.75M -12.4%
Revenue (ttm)	277.12M -4.7%
Net Income	44.74M +5.3%
EPS	1.75 +5.8%
Shares Out	25.61M
PE Ratio	16.60
Forward PE	n/a
Dividend	1.50 (5.16%)
Ex-Dividend Date	Aug 7, 2025

Volume	2,018
Average Volume	13,087
Open	29.00
Previous Close	29.00
Day's Range	28.95 - 29.00
52-Week Range	28.05 - 35.80
Beta	0.17
RSI	38.74
Earnings Date	Mar 27, 2026

About BioLASCO Taiwan

BioLASCO Taiwan Co., Ltd. operates an animal breeding center to produce specific pathogen-free laboratory mice and rats in Taiwan and internationally. It offers lab animals, such as rat, mice, and others, as well as surgical services; rodents housing, washing solutions, workstations, animal housing and management solutions, lab animal research equipment, clean solution, preclinical imaging system, and experimental equipment; various reagents, including lab animal diagnostic reagent, endotoxin testing system, portable endotoxin testing system, r...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1990
• Employees: 91
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6662

Financial Performance

In 2024, BioLASCO Taiwan's revenue was 292.50 million, an increase of 10.49% compared to the previous year's 264.72 million. Earnings were 44.03 million, a decrease of -11.49%.